Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
17
pubmed:dateCreated
1992-9-29
pubmed:abstractText
A lactococcal bacteriocin, termed lactococcin G, was purified to homogeneity by a simple four-step purification procedure that includes ammonium sulfate precipitation, binding to a cation exchanger and octyl-Sepharose CL-4B, and reverse-phase chromatography. The final yield was about 20%, and nearly a 7,000-fold increase in the specific activity was obtained. The bacteriocin activity was associated with three peptides, termed alpha 1, alpha 2, and beta, which were separated by reverse-phase chromatography. Judging from their amino acid sequences, alpha 1 and alpha 2 were the same gene product. Differences in their configurations presumably resulted in alpha 2 having a slightly lower affinity for the reverse-phase column than alpha 1 and a reduced bacteriocin activity when combined with beta. Bacteriocin activity required the complementary action of both the alpha and the beta peptides. When neither alpha 1 nor beta was in excess, about 0.3 nM alpha 1 and 0.04 nM beta induced 50% growth inhibition, suggesting that they might interact in a 7:1 or 8:1 ratio. As judged by the amino acid sequence, alpha 1 has an isoelectric point of 10.9, an extinction coefficient of 1.3 x 10(4) M-1 cm-1, and a molecular weight of 4,346 (39 amino acid residues long). Similarly, beta has an isoelectric point of 10.4, an extinction coefficient of 2.4 x 10(4) M-1 cm-1, and a molecular weight of 4110 (35 amino acid residues long). Molecular weights of 4,376 and 4,109 for alpha 1 and beta, respectively, were obtained by mass spectrometry. The N-terminal halves of both the alpha and beta peptides may form amphiphilic alpha-helices, suggesting that the peptides are pore-forming toxins that create cell membrane channels through a "barrel-stave" mechanism. The C-terminal halves of both peptides consist largely of polar amino acids.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/1512201-1622206, http://linkedlifedata.com/resource/pubmed/commentcorrection/1512201-16346166, http://linkedlifedata.com/resource/pubmed/commentcorrection/1512201-16348628, http://linkedlifedata.com/resource/pubmed/commentcorrection/1512201-1654003, http://linkedlifedata.com/resource/pubmed/commentcorrection/1512201-1744049, http://linkedlifedata.com/resource/pubmed/commentcorrection/1512201-1840587, http://linkedlifedata.com/resource/pubmed/commentcorrection/1512201-1872611, http://linkedlifedata.com/resource/pubmed/commentcorrection/1512201-1900281, http://linkedlifedata.com/resource/pubmed/commentcorrection/1512201-1901707, http://linkedlifedata.com/resource/pubmed/commentcorrection/1512201-1903624, http://linkedlifedata.com/resource/pubmed/commentcorrection/1512201-1904860, http://linkedlifedata.com/resource/pubmed/commentcorrection/1512201-1931137, http://linkedlifedata.com/resource/pubmed/commentcorrection/1512201-2076469, http://linkedlifedata.com/resource/pubmed/commentcorrection/1512201-2118169, http://linkedlifedata.com/resource/pubmed/commentcorrection/1512201-2453923, http://linkedlifedata.com/resource/pubmed/commentcorrection/1512201-2493449, http://linkedlifedata.com/resource/pubmed/commentcorrection/1512201-3135807, http://linkedlifedata.com/resource/pubmed/commentcorrection/1512201-3141403, http://linkedlifedata.com/resource/pubmed/commentcorrection/1512201-3442448, http://linkedlifedata.com/resource/pubmed/commentcorrection/1512201-5131162, http://linkedlifedata.com/resource/pubmed/commentcorrection/1512201-6087394, http://linkedlifedata.com/resource/pubmed/commentcorrection/1512201-791239
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0021-9193
pubmed:author
pubmed:issnType
Print
pubmed:volume
174
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
5686-92
pubmed:dateRevised
2010-9-7
pubmed:meshHeading
pubmed:year
1992
pubmed:articleTitle
A novel lactococcal bacteriocin whose activity depends on the complementary action of two peptides.
pubmed:affiliation
Laboratory of Microbial Gene Technology, NLVF, As, Norway.
pubmed:publicationType
Journal Article, Comparative Study, Research Support, Non-U.S. Gov't